Iovance Biotherapeutics, Inc. (IOVA) SEC Filings — 2024

Filings

• IOVANCE BIOTHERAPEUTICS, INC. Enters and Terminates Agreements — 8-K · Nov 21, 2024
• Iovance Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K — 8-K · Nov 8, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K on Financials — 8-K · Nov 7, 2024
• IOVANCE BIOTHERAPEUTICS Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Iovance Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Oct 18, 2024
• IOVANCE BIOTHERAPEUTICS APPOINTS NEW CHIEF MEDICAL OFFICER — 8-K · Aug 9, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K on Financials — 8-K · Aug 8, 2024
• IOVANCE BIOTHERAPEUTICS Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• IOVANCE BIOTHERAPEUTICS FILES 8-K — 8-K · Jun 28, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K on Security Holder Vote — 8-K · Jun 11, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K — 8-K · Jun 3, 2024
• IOVANCE BIOTHERAPEUTICS APPOINTS NEW CHIEF MEDICAL OFFICER — 8-K · May 24, 2024
• IOVA Proxy Statement Filed — DEFA14A · May 17, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K on Financials — 8-K · May 9, 2024
• IOVA Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• IOVA Files DEF 14A — DEF 14A · Apr 29, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K — 8-K · Apr 3, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K: Board & Executive Changes — 8-K · Mar 29, 2024
• Rothbaum Amends Iovance Stake Filing — SC 13D/A · Mar 19, 2024
• IOVANCE BIOTHERAPEUTICS FILES 8-K — 8-K · Mar 4, 2024
• Iovance Biotherapeutics, Inc. SC 13G Filing — SC 13G · Mar 1, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K on Other Events and Financials — 8-K · Feb 29, 2024
• Iovance Biotherapeutics Files 8-K on Financial Condition — 8-K · Feb 28, 2024
• IOVANCE BIOTHERAPEUTICS, INC. Files 2023 10-K — 10-K · Feb 28, 2024
• Iovance Biotherapeutics Files 8-K for Other Events and Exhibits — 8-K · Feb 22, 2024
• Iovance Bio Files 8-K on Operations and Financial Condition — 8-K · Feb 20, 2024
• Iovance Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Iovance Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Iovance Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• MHR Fund Management Affirms Significant Stake in Iovance Biotherapeutics — SC 13G/A · Feb 9, 2024
• IOVANCE Files 8-K for Simultaneous Communication Obligations — 8-K · Jan 26, 2024
• BlackRock Maintains 6.0% Stake in Iovance Biotherapeutics — SC 13G/A · Jan 26, 2024
• State Street Lowers Iovance Biotherapeutics Stake to 3.8% — SC 13G/A · Jan 25, 2024
• IOVANCE BIOTHERAPEUTICS Files 8-K for 'Other Events' & Exhibits — 8-K · Jan 8, 2024